Tau phosphorylation in Alzheimer's disease: pathogen or protector?

Hyoung‐gon Lee; George Perry; Paula I. Moreira; Matthew R. Garrett; Quan Liu; Xiongwei Zhu; Atsushi Takeda; Akihiko Nunomura; Mark A. Smith

doi:10.1016/j.molmed.2005.02.008

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Chapter in a book2006

The Changing landscape of Alzheimer’s disease: From Insoluble to Soluble and from Pathogen to Protector

Mark A. Smith, George Perry

Article2008

Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease

Siddhartha Mondragón‐Rodríguez, Gustavo Basurto‐Islas, Ismael Santa‐María, Raúl Mena, Lester I. Binder, Jesús Ávila, Mark A. Smith, George Perry, Francisco García‐Sierra

Article2007

c‐Jun phosphorylation in Alzheimer disease

Akanksha Thakur, Xinglong Wang, Sandra L. Siedlak, George Perry, Mark A. Smith, Xiongwei Zhu

Article2014

Promoter hypermethylation of the phosphatase DUSP22 mediates PKA‐dependent TAU phosphorylation and CREB activation in Alzheimer's disease

José V. Sánchez‐Mut, Ester Aso, Holger Heyn, Tadashi Matsuda, Christoph Bock, Isidró Ferrer, Manel Esteller

Article2000

Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle-Related Events in Alzheimer Disease

Xiongwei Zhu, Catherine A. Rottkamp, Heather Boux, Atushi Takeda, George Perry, Mark A. Smith